Terms: = Leukemia AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
118 results:
1. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
Hampel PJ; Swaminathan M; Rogers KA; Parry EM; Burger JA; Davids MS; Ding W; Ferrajoli A; Hyak JM; Jain N; Kenderian SS; Wang Y; Wierda WG; Woyach JA; Parikh SA; Thompson PA
Blood Adv; 2024 May; 8(10):2342-2350. PubMed ID: 38537065
[TBL] [Abstract] [Full Text] [Related]
2. Poor Outcome of Adult T-Cell leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers.
Saeed H; Sandoval-Sus J; Castillo-Tokumori F; Dong N; Pullukkara JJ; Boisclair S; Brahim A; Walker D; Bridgellal S; Zhang L; Sokol L
Oncol Res Treat; 2023; 46(11):459-465. PubMed ID: 37844559
[TBL] [Abstract] [Full Text] [Related]
3. The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma.
Roh J; Pak HK; Jeong S; Hwang S; Kim DE; Choi HS; Kim SJ; Kim H; Cho H; Park JS; Jeong SH; Choi YS; Han JH; Yoon DH; Park CS
Biochem Biophys Res Commun; 2023 Sep; 673():36-43. PubMed ID: 37356143
[TBL] [Abstract] [Full Text] [Related]
4. RNA sequencing of myeloid sarcoma, shed light on myeloid sarcoma stratification.
Yang Y; Shu Y; Tang Y; Zhao S; Jia Y; Ji J; Ma H; Lin T; Zheng K; Xu H; Wu Y
Cancer Med; 2023 Apr; 12(8):9156-9166. PubMed ID: 36916780
[TBL] [Abstract] [Full Text] [Related]
5. UBTF-internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia.
Kaburagi T; Shiba N; Yamato G; Yoshida K; Tabuchi K; Ohki K; Ishikita E; Hara Y; Shiraishi Y; Kawasaki H; Sotomatsu M; Takizawa T; Taki T; Kiyokawa N; Tomizawa D; Horibe K; Miyano S; Taga T; Adachi S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2023 Apr; 62(4):202-209. PubMed ID: 36448876
[TBL] [Abstract] [Full Text] [Related]
6. tls/fus-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
Zhang H; Zhan Q; Wang X; Gao F; Yu J; Wang J; Fu W; Wang P; Wei X; Zhang L
Ann Hematol; 2022 Dec; 101(12):2583-2600. PubMed ID: 36181538
[TBL] [Abstract] [Full Text] [Related]
7. A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.
Wang X; Hong Y; Meng S; Gong W; Ren T; Zhang T; Liu X; Li L; Qiu L; Qian Z; Zhou S; Zhao M; Zhai Q; Meng B; Ren X; Zhang H; Wang X
Clin Immunol; 2022 Oct; 243():109105. PubMed ID: 36055572
[TBL] [Abstract] [Full Text] [Related]
8. The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and tls-ERG gene fusion: A case report.
Gao L; Xu Y; Tian Z; Xia J; Yuan Z; Chen D; Ren M
Medicine (Baltimore); 2022 May; 101(21):e29475. PubMed ID: 35623083
[TBL] [Abstract] [Full Text] [Related]
9. A novel HNRNPH1::ERG rearrangement in aggressive acute myeloid leukemia.
Jiang F; Lang X; Chen N; Jin L; Liu L; Wei X; Pan J; Yu F; Blake A; Xiao S
Genes Chromosomes Cancer; 2022 Aug; 61(8):503-508. PubMed ID: 35503261
[TBL] [Abstract] [Full Text] [Related]
10. Management of Peripheral T-Cell Lymphoma in Children and Adolescents Including STAT 3 Mutation Hyper-IgE Syndrome: One Size Does Not Fit All.
Ravichandran N; Uppuluri R; Vellaichamy Swaminathan V; Melarcode Ramanan K; Meena S; Varla H; Chandar R; Jayakumar I; Raj R
J Pediatr Hematol Oncol; 2022 May; 44(4):e849-e854. PubMed ID: 34862350
[TBL] [Abstract] [Full Text] [Related]
11. Indeterminate and oncogenic potential: CHIP vs chop mutations in AML with NPM1 alteration.
Cappelli LV; Meggendorfer M; Baer C; Nadarajah N; Hutter S; Jeromin S; Dicker F; Kern W; Haferlach T; Haferlach C; Höllein A
Leukemia; 2022 Feb; 36(2):394-402. PubMed ID: 34376804
[TBL] [Abstract] [Full Text] [Related]
12. Rare and favorable prognosis of pediatric acute lymphoblastic leukemia with tls-ERG fusion gene: Case report with long-term follow-up and review of literature.
Li S; Huang W; Wu Y; Xu X; Liao C; Tang Y
Cancer Genet; 2021 Aug; 256-257():51-56. PubMed ID: 33894645
[TBL] [Abstract] [Full Text] [Related]
13. Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4
Falgàs A; Pallarès V; Unzueta U; Núñez Y; Sierra J; Gallardo A; Alba-Castellón L; Mangues MA; Álamo P; Villaverde A; Vázquez E; Mangues R; Casanova I
Int J Nanomedicine; 2021; 16():1869-1888. PubMed ID: 33716502
[TBL] [Abstract] [Full Text] [Related]
14. Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.
Imoto N; Koyama D; Sugiura I; Kurahashi S
Medicine (Baltimore); 2021 Feb; 100(5):e24457. PubMed ID: 33592897
[TBL] [Abstract] [Full Text] [Related]
15. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.
Klintman J; Appleby N; Stamatopoulos B; Ridout K; Eyre TA; Robbe P; Pascua LL; Knight SJL; Dreau H; Cabes M; Popitsch N; Ehinger M; Martín-Subero JI; Campo E; Månsson R; Rossi D; Taylor JC; Vavoulis DV; Schuh A
Blood; 2021 May; 137(20):2800-2816. PubMed ID: 33206936
[TBL] [Abstract] [Full Text] [Related]
16. Hyperleukocytosis and Leukostasis in Acute Myeloid leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP; Zeidan AM
Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
[TBL] [Abstract] [Full Text] [Related]
17. prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K;
Cancer Sci; 2020 Dec; 111(12):4567-4580. PubMed ID: 32976684
[TBL] [Abstract] [Full Text] [Related]
18. De Novo CD5
Xu Y; Sun W; Li F
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e782-e790. PubMed ID: 32694049
[TBL] [Abstract] [Full Text] [Related]
19. Subcutaneous Masses as an Unusual Manifestation of Relapse in a Case of Atypical Chronic Lymphocytic leukemia with Prolymphocytoid Transformation and Complex Karyotype: A Diagnostic Dilemma and Treatment Challenge.
Aldapt MB; Soliman D; Szabados L; Sharaf Eldean MZ; Shwaylia HM; Abdulla MAJ; Yassin MA
Am J Case Rep; 2020 May; 21():e920411. PubMed ID: 32388531
[TBL] [Abstract] [Full Text] [Related]
20. Activation of PERK-ATF4-chop pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells.
Ikebe E; Matsuoka S; Tezuka K; Kuramitsu M; Okuma K; Nakashima M; Kobayashi S; Makiyama J; Yamagishi M; Oyadomari S; Uchimaru K; Hamaguchi I
Blood Adv; 2020 May; 4(9):1845-1858. PubMed ID: 32369565
[TBL] [Abstract] [Full Text] [Related]
[Next]
